Clinical Trial 52232

Philadelphia, PA 19114


Migraine - Philadelphia PA
Click image to enlarge

Migraine Research Study

See if you are eligible to participate in a local research study for an investigational medication for patients with migraine

  • Must be aged 18 or older
  • Must be diagnosed with migraine for at least 1 year
  • Currently or within the past 4 weeks have taken any of the following medication (oral gepants): Rimegepant (Nurtec) or Ubrogepant (Ubrelvy) for the treatment of at least 4 migraines
  • Experiencing migraines or have an inadequate response after taking the above medications

Qualified Participants May Receive:

Participants will receive investigational medication and study-related care at no cost.

Study includes up to 4 in-office visits over 10 weeks.

Compensation may be available for travel and time.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.